Raburn M Mallory

Summary

Affiliation: MedImmune Vaccines
Country: USA

Publications

  1. pmc Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials
    Raburn M Mallory
    MedImmune, LLC, Gaithersburg, Maryland, United States of America
    PLoS ONE 5:e13755. 2010
  2. doi request reprint Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age
    Raburn M Mallory
    MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA
    Vaccine 29:4322-7. 2011
  3. doi request reprint The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
    Christopher S Ambrose
    MedImmune, LLC, Gaithersburg, MD 20878, USA
    Vaccine 30:6794-801. 2012

Detail Information

Publications3

  1. pmc Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials
    Raburn M Mallory
    MedImmune, LLC, Gaithersburg, Maryland, United States of America
    PLoS ONE 5:e13755. 2010
    ..The safety, tolerability, and immunogenicity of a monovalent intranasal 2009 A/H1N1 live attenuated influenza vaccine (LAIV) were evaluated in children and adults...
  2. doi request reprint Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age
    Raburn M Mallory
    MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA
    Vaccine 29:4322-7. 2011
    ..The incidence, duration, and other parameters of viral shedding after vaccination with LAIV have not been fully described in children ≤ 5 years of age...
  3. doi request reprint The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
    Christopher S Ambrose
    MedImmune, LLC, Gaithersburg, MD 20878, USA
    Vaccine 30:6794-801. 2012
    ..The role of IgA in providing protection against influenza in children vaccinated with live attenuated influenza vaccine (LAIV) has not been well described...